Finally, other strong Nrf2 activators (such as organosulfur compounds or regular exercise) should be tested alongside CDDO-Me and any other compound suspected of causing Nrf2-mediated cardiomyopathy. The gene discussed is NFE2L2; the disease is cardiomyopathy.